CN101829372A - Blood cell apoptosis inducible system - Google Patents

Blood cell apoptosis inducible system Download PDF

Info

Publication number
CN101829372A
CN101829372A CN 201010175241 CN201010175241A CN101829372A CN 101829372 A CN101829372 A CN 101829372A CN 201010175241 CN201010175241 CN 201010175241 CN 201010175241 A CN201010175241 A CN 201010175241A CN 101829372 A CN101829372 A CN 101829372A
Authority
CN
China
Prior art keywords
blood cell
water tank
cell apoptosis
treatment
equipment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 201010175241
Other languages
Chinese (zh)
Inventor
张振刚
居小平
冯海友
龚开政
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SINOWAYS MEDICAL TECHNOLOGY Co Ltd
Original Assignee
SINOWAYS MEDICAL TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SINOWAYS MEDICAL TECHNOLOGY Co Ltd filed Critical SINOWAYS MEDICAL TECHNOLOGY Co Ltd
Priority to CN 201010175241 priority Critical patent/CN101829372A/en
Publication of CN101829372A publication Critical patent/CN101829372A/en
Pending legal-status Critical Current

Links

Images

Abstract

The invention relates to the technical field of medical treatment and discloses equipment for performing comprehensive physical stimulation on in-vitro blood cells. The equipment comprises a constant-temperature water tank, wherein an ultraviolet radiation device is arranged above the water tank; a quartz glass container is arranged in the water tank; and the two sides on the upper part of the container are connected with an ozone input pipe and an ozone outlet pipe. The equipment is simple in structure, easy in production and convenient in operation respectively. The concept and the method for treating the cardiac failure are groundbreaking. The invention provides a blood cell apoptosis inducible processing system which is researched according to the brand new treatment concept and method and provides a new path to the treatment for chronic inflammation over-activated diseases, such as cardiac failure.

Description

Blood cell apoptosis inducible system
Technical field
The present invention relates to field of medical technology, is a kind of equipment that in-vitro blood cells is carried out comprehensive physical stimulation.
Background technology
Over year, the research data of different researchers shows that the hemocyte of apoptosis has immunoregulation effect, may have therapeutical effect to the panimmunity disease surplus in the of nearly 10.And then certain company of Canada is name with Celacade, has set up the equipment of inducing blood cell apoptosis by comprehensive physical stimulation, through this processing, can make the hemocyte generation apoptosis more than 80%.They are applied to panimmunity abnormity disease treatment research field with this method, wherein, have showed good prospect for the treatment of heart failure.
Heart failure has sickness rate height, disability rate height and the high characteristics of fatality rate, is called as last fort of not captured of cardiovascular disease prevention and control field.The various Therapeutic Method in the comprehensive present age, its 5 annual death rate still may surpass 50% (male) or 30% (women).In recent years, in the research to heart failure generation development mechanism, recognize progressively that inflammatory factor and immune activation state are the important mechanisms that heart failure runs down.Different researchers has successively been attempted multiple different medicine and biological method, and patients with heart failure is carried out immunologic intervention, but does not all obtain positive effect.One causes studies show that academia pays much attention to, apoptotic blood will take place re-enter in patient's body, can make gently, 2 years admission rates of moderate patients with heart failure and mortality rate reduce nearly 30%, for new prospect has been showed in the treatment of heart failure.In the control of arteriosclerotic disease, this method has also shown attractive result.But up at present, China does not set up effectively stable blood cell apoptosis inducible system as yet, does not also have the scholar deeply to get involved this research field.
Summary of the invention
The object of the invention is to design and a kind ofly realizes stablizing, in-vitro blood cells apoptosis induced device efficiently.
The present invention includes thermostatic water bath, ultraviolet lamp is set, in tank, place quartz container, connect ozone gas input channel and output channel respectively in the both sides on described container top in the tank top.
From a certain amount of blood of patient's withdraw (10ml), through above external evoked processing system, make blood be in the environmental stimulus of certain density ozone, ultraviolet radiation and temperature simultaneously, make the cell generation apoptosis more than 80%, intramuscular injection is returned in former patient's body then, thereby reach the autoimmune regulating action, suppress strong excessively inflammatory conditions in the body.
The present invention is simple in structure, be easy to produce, handled easily.The theory of above-mentioned treatment heart failure and method are initiative, the present invention is that the blood cell apoptosis of developing according to above-mentioned brand-new treatment theory and method is induced processing system, for chronic inflammatory disease excessive activation diseases such as treatment heart failure provide a kind of new approach.
Description of drawings
Fig. 1 is a kind of structural representation of the present invention.
The specific embodiment
As shown in Figure 1, the quartz burner 4 of band ultraviolet protection cover is set above thermostatic water bath 5, the container of in tank 5, making 3 by support 7 fixed placement quartz glasss, the both sides on container 3 tops connect ozone gas input channel 1 and output channel 6 respectively.
Blood cell apoptosis is induced processing procedure: open ozone gas generation equipment and produce ozone gas, the water temperature in the control tank 5 is placed on the container 3 that fresh blood 2 is housed on the support 7, and makes blood 2 be immersed in below the water level of tank 5 3/4 of the about container of the degree of depth; Open quartz burner 4, open the valve of ozone gas input channel 1 and output channel 6 simultaneously, when ozone gas by blood 2 surfaces and simultaneously under temperature and action of ultraviolet ray, hemocyte is subjected to apoptosis induction and handles.
Through (time according to ultraviolet light intensity a little less than degree and ozone gas solubility set) after several minutes, the activity of hemocyte drops to 20% of normal value after tested, and promptly blood cell apoptosis 80%.Close Burdick lamp and switching and close ozone gas input and output valve, fetch quartz container 3, obtain the blood of handling through apoptosis induction.

Claims (1)

1. blood cell apoptosis inducible system is characterized in that comprising thermostatic water bath, in the tank top ultraviolet lamp is set, and places quartz container in tank, connects ozone gas input channel and output channel respectively in the both sides on described container top.
CN 201010175241 2010-05-11 2010-05-11 Blood cell apoptosis inducible system Pending CN101829372A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201010175241 CN101829372A (en) 2010-05-11 2010-05-11 Blood cell apoptosis inducible system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201010175241 CN101829372A (en) 2010-05-11 2010-05-11 Blood cell apoptosis inducible system

Publications (1)

Publication Number Publication Date
CN101829372A true CN101829372A (en) 2010-09-15

Family

ID=42713690

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201010175241 Pending CN101829372A (en) 2010-05-11 2010-05-11 Blood cell apoptosis inducible system

Country Status (1)

Country Link
CN (1) CN101829372A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101843931A (en) * 2010-05-19 2010-09-29 江苏中惠医疗科技股份有限公司 Blood cell apoptosis inducing method

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4968483A (en) * 1987-01-15 1990-11-06 Quarzlampenfabrik Dr.-Ing. Felix W. Muller Gmbh & Co. Kg Apparatus for the production of oxygenated blood
US5591457A (en) * 1992-02-07 1997-01-07 Vasogen Inc Method of inhibiting the aggregation of blood platelets and stimulating the immune systems of a human
CN1400906A (en) * 2000-01-18 2003-03-05 瓦索根爱尔兰有限公司 Treatment of congestive heart failure by pretreated autologous blood
CN201676334U (en) * 2010-05-11 2010-12-22 江苏中惠医疗科技股份有限公司 Blood cell apoptosis induction system

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4968483A (en) * 1987-01-15 1990-11-06 Quarzlampenfabrik Dr.-Ing. Felix W. Muller Gmbh & Co. Kg Apparatus for the production of oxygenated blood
US5591457A (en) * 1992-02-07 1997-01-07 Vasogen Inc Method of inhibiting the aggregation of blood platelets and stimulating the immune systems of a human
CN1400906A (en) * 2000-01-18 2003-03-05 瓦索根爱尔兰有限公司 Treatment of congestive heart failure by pretreated autologous blood
CN201676334U (en) * 2010-05-11 2010-12-22 江苏中惠医疗科技股份有限公司 Blood cell apoptosis induction system

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101843931A (en) * 2010-05-19 2010-09-29 江苏中惠医疗科技股份有限公司 Blood cell apoptosis inducing method

Similar Documents

Publication Publication Date Title
CN206366102U (en) A kind of multispectral diabetes curing instrument
Tsuji et al. Painful diabetic neuropathy in Japanese diabetic patients is common but underrecognized
CN201676334U (en) Blood cell apoptosis induction system
Pan et al. Traditional medicines in the world: where to go next?
US20220266046A1 (en) Apparatus for systemic human enhancement from administration of frequency therapy including enhanced stem cell and genetic therapy and methods for using same
CN105617540A (en) Light supplementing health preserving instrument
CN104672293B (en) Pentacyclic triterpene structure modified compound as well as preparation method and application thereof
CN101829372A (en) Blood cell apoptosis inducible system
CN201710827U (en) Neonatal jaundice phototherapeutic lamp
CN113952581A (en) Multi-functional autism intervenes treatment device
CN202141116U (en) Bath heater with sunbath function
CN207493066U (en) Submerged type blue-light treatment strip of light
CN101843931A (en) Blood cell apoptosis inducing method
CN113952588A (en) Autism treatment device
CN209361678U (en) A kind of novel Icterus treatment box fence
Dai et al. Effect of Acupuncture on Serum SOD and MDA of Rats in Menopause
CN113893430A (en) Device is intervene to autism
CN102836056A (en) Traditional Chinese medicine fumigator with seat
CN209137196U (en) It is a kind of for treating the therapeutic bed of hyperbilirubinemia of newborn
Cahyaningrum et al. Pengaruh Berjemur Terhadap Regulasi Emosi Pasien Dengan Resiko Perilaku Kekerasan Di Rsjd Dr. Amino Gondohutomo
Zhang et al. Effects of laser irradiation of acupuncture points Shenshu on ovariectomized rats
CN207186832U (en) A kind of Chinese medicine bamboo jar treatment center
CN106138098A (en) Natural killer cell associating antidepressants application in improving depressive symptom
CN117100728A (en) Application of metformin in inhibiting sebaceous gland cell function and activity
Xue et al. Hyperbaric Oxygen Therapy Improve Acute Graft-Versus-Host Disease By Activating the Nrf2/HO-1 Pathway in a Mice Model

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20100915